References
- Utili R., Boitnott J. K., Zimmerman H. J. Dantrolene-associated hepatic injury. Gastroenterology (1977); 72: 610
- Ogburn R. M., Myers R. L., Burdick G. E. Hepatitis associated with dantrolene sodium. Am. Intern. Med. (1976); 84: 54
- Abernathy C O., Utili R., Zimmerman H. J., Ezekiel M. The effects of dantrolene sodium on excretory function in the isolated perfused rat liver. Tox. Appl. Pharm. (1978); 44: 441
- Francis K. T., Hamrick M. E. Dantrolene inhibition of the hepatic mixed function oxidase system. Res. Comm. Chem. Pathol. Pharmacol. (1979); 23: 69
- Francis K. T., Hamrick M. E. Effect of dantrolene on adrenal cortical function. Biochem. Pharmacol. (1980); 29: 1669
- Roy S., Francis K. T., Born C. K., Hamrick K. Interaction of dantrolene with the hepatic mixed function oxidase. Res. Comm. Chem. Pathol. Pharmacol. (1980); 3: 507
- Arnold T. H., Jr., Epps J. M., III, Cook H. R., Hamrick M. E. Dantrolene sodium: Urinary metabolites and hepatotoxicity. Res. Comm. Chem. Pathol. Pharmacol., 39: 381, (983)
- Hollifield R. D., Conklin J. D. Determination of dantrolene in biological specimens containing drug-related metabolites. J. Pharm. Sci. (1973); 62: 271
- MacDonald J. R., Gandolfi A. J., Sipes I. G. Acetone potentiation of 1,1,2-trichloroethane hepatotoxicity. Toxicol Letters (1982); 13: 57
- Gandolfi A. J., White R. D., Sipes I. G., Pohl L. R. Bioactivation and covalent binding of halothane in vitro. J. Pharmacol. Exp. Ther. (1980); 214: 721
- Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. (1964); 239: 2370
- Gornall A. G., Bardawill C. S., David M. D. Protein measurement with the Biuret reagent. J. Biol. Chem. (1949); 177: 751
- Wroblewski F., LaDue J. S. Serum glutamic-pyruvic transaminase in cardiac and hepatic disease. proc. Soc. Exp. Biol. Med. (1956); 91: 569
- Gandolfi A. J., MacDonald J. R., Sipes I. G. Comparative microsomal bioactivation of organohalogens. Pharmacologist (1979); 21: 194
- Wood M., Berman M. L., Harbison R. D., Hoyle P., Phythyon J. M., Wood A. J.J. Halothane-induced hepatic necrosis in triiodothyronine-pretreated animals. Anesthesiology (1980); 52: 470
- Johnson M. K. The influence of some aliphatic compounds on rat liver glutathione levels. Biochem. Pharmacol. (1965); 14: 1383
- Sun J. D., Dent J. G. A new method for measuring covalent binding of chemicals to cellular macromolecules. Chem.-Biol. Interactions (1980); 32: 41
- Durham J. A., Grandolfi A. J., Bentley J. B. Hepatotoxicological evaluation of dantrolene sodium. Toxicologist (1983); 3: 130
- Wang C. Y., Behrens B. C., Ichiwaka M., Bryan G. T. Nitro-reduction of 5-nitrofuran derivatives by rat liver xanthine oxidase and reduced nicotinamide adenine dinucleo-tide phosphate-cytochrome c reductase. Biochem. Pharmacol. (1974); 23: 3395
- Mitchell J. R., Nelson W. L., Potter W. Z., Sasame H. A., Jollow D. J. Metabolic activation of furosemide to a chemically reactive, hepatotoxic metabolite. J. Pharmacol. Exp. Ther. (1976); 199: 41
- Guengerich F. P. Studies on the activation of a model furan compound—toxicity and covalent binding of 2-(N-ethylcarbamoyl-hydroxymethyl) furan. Biochem. Pharmacol. (1977); 26: 1909